市場調査レポート

商品コード

1619044

疼痛管理の市場規模、シェア、成長分析、タイプ別、適応症別、購入形態別、エンドユーザー別、地域別 - 産業予測、2024～2031年

Pain Management Market Size, Share, Growth Analysis, By Types (Non-Steroidal Anti-Inflammatory Drugs, Anticonvulsants), By Indication, By Mode of Purchase, By End-User, By Region - Industry Forecast 2024-2031

出版日: 2024年12月18日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 760,921円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 890,134円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,019,347円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
目次

概要

サンプル依頼リストに入れる

疼痛管理の世界市場規模は2022年に752億米ドルと評価され、2023年の784億3,000万米ドルから2031年には1,098億4,000万米ドルに成長し、予測期間（2024～2031年）のCAGRは4.3％で成長する見通しです。

世界の疼痛管理市場は、関節炎、がん性疼痛、筋骨格系障害などの慢性疼痛疾患の有病率の上昇に後押しされ、力強い成長を遂げています。慢性疼痛は日常生活に大きな影響を与えるため、効果的な疼痛緩和ソリューションへの需要が高まっています。新規医薬品や低侵襲手技を含む技術や治療オプションの進歩により、医療従事者が痛みを効果的に管理するためのアプローチが強化されています。しかし、市場はオピオイド危機などの課題に直面しており、規制の強化や非オピオイド代替薬へのシフトが進んでいます。さらに、高額な治療費とさまざまな償還政策により、十分なサービスを受けていない人々のアクセスが制限される可能性もあります。痛みの主観的な性質は個別化された治療戦略を複雑にしており、各患者の状況を微妙に理解する必要があります。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情報

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場の最近の動向
企業の市場シェア分析（2023年）
主要企業の企業プロファイル
- 会社概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較（2021～2023年）

主要企業プロファイル

Teva Pharmaceutical
Pfizer
Abbott
Mallinckrodt Pharmaceuticals
Endo International
GlaxoSmithKline
AstraZeneca
Depomed
Merck
Novartis
Eli Lilly and Company
Genentech
Tonix Pharmaceuticals
NeuSpera Medical
Oculis
Aspen Laser
Hyperice
Orofacial Therapeutics Inc.
Pain Care Labs
Medtronic

結論と推奨事項

Product Code: SQMIG35I2271

Global Pain Management Market size was valued at USD 75.2 billion in 2022 and is poised to grow from USD 78.43 billion in 2023 to USD 109.84 billion by 2031, growing at a CAGR of 4.3% during the forecast period (2024-2031).

The global pain management market is experiencing robust growth, fueled by the rising prevalence of chronic pain conditions like arthritis, cancer pain, and musculoskeletal disorders. As chronic pain significantly impacts daily life, the demand for effective pain relief solutions is escalating. Advances in technology and treatment options, including novel pharmaceuticals and minimally invasive procedures, enhance the approach healthcare professionals can take to manage pain effectively. However, the market faces challenges such as the opioid crisis, leading to heightened regulations and a shift towards non-opioid alternatives. Additionally, high treatment costs and varying reimbursement policies can limit access for underserved populations. The subjective nature of pain complicates personalized treatment strategies, necessitating a nuanced understanding of each patient's situation.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Pain Management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Pain Management Market Segmental Analysis

Global Pain Management Market is segmented by types, indication, mode of purchase, end-user and region. Based on types, the market is segmented into non-steroidal anti-inflammatory drugs (NSAIDS), anticonvulsants, sedatives, narcotics, antimigraine specialists, antidepressants and others. Based on indication, the market is segmented into delegated neuropathic torment, disease torment, facial agony and headache, musculoskeletal torment, fibromyalgia, persistent back torment, joint torment, headache and post-usable torment. Based on mode of purchase, the market is segmented into over the counter and solution-based. Based on end-user, the market is segmented into emergency clinics and facilities, drug organizations, clinical gadget organizations, examination and educational establishments. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Pain Management Market

The Global Pain Management market is significantly driven by a heightened awareness regarding the effects of pain on individuals' quality of life. As healthcare providers, patients, and policymakers increasingly recognize the importance of effective pain relief, there's a concerted effort aimed at enhancing research, education, and accessibility to pain management solutions. This growing commitment to patient-centric care coupled with the desire for improved outcomes in pain management is propelling the market forward. Emphasizing effective strategies for relieving pain not only benefits individuals but also fosters advancements in the overall healthcare landscape, further driving interest and investment in this vital sector.

Restraints in the Global Pain Management Market

The Global Pain Management market faces significant constraints due to the high expense associated with treatments. Advanced procedures, devices, and specialized therapies often come with steep price tags that can hinder market growth. This financial barrier particularly affects access for various patient populations, particularly in low-income areas or countries with constrained healthcare resources. Consequently, many individuals may be unable to afford necessary pain management interventions, which can result in untreated conditions and overall suboptimal health outcomes. As a result, the high cost of these treatments remains a critical factor slowing the expansion of the pain management market worldwide.

Market Trends of the Global Pain Management Market

The Global Pain Management market is experiencing a significant trend towards multimodal and individualized approaches, reflecting a shift in how pain is managed. This trend encompasses the integration of diverse therapies-ranging from pharmacological treatments and physical therapy to psychological interventions and lifestyle modifications-allowing for comprehensive care that addresses pain from multiple dimensions. As healthcare providers increasingly recognize the importance of tailoring pain management strategies to each patient's unique circumstances-including the nature of their pain, existing comorbidities, and personal preferences-this evolving paradigm is expected to enhance patient outcomes and drive substantial growth within the market through more effective, personalized treatment options.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Regulatory Landscape
Case Studies

Global Pain Management Market Size by Types & CAGR (2024-2031)

Market Overview
Non-Steroidal Anti-Inflammatory Drugs (Nsaids)
Anticonvulsants
Sedatives
Narcotics
Antimigraine Specialists
Antidepressants
Others

Global Pain Management Market Size by Indication & CAGR (2024-2031)

Market Overview
Delegated Neuropathic Torment
Disease Torment
Facial Agony and Headache
Musculoskeletal Torment
Fibromyalgia
Persistent Back Torment
Joint Torment
Headache
Post-Usable Torment

Global Pain Management Market Size by Mode Of Purchase & CAGR (2024-2031)

Market Overview
Over The Counter
Solution-Based

Global Pain Management Market Size by End-User & CAGR (2024-2031)

Market Overview
Emergency Clinics and Facilities
Drug Organizations
Clinical Gadget Organizations
Examination
Educational Establishments

Global Pain Management Market Size & CAGR (2024-2031)

North America (Types, Indication, Mode of Purchase, End-User)
- USA
- Canada
Europe (Types, Indication, Mode of Purchase, End-User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Types, Indication, Mode of Purchase, End-User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Types, Indication, Mode of Purchase, End-User)
- Brazil
- Rest of Latin America
Middle East & Africa (Types, Indication, Mode of Purchase, End-User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Teva Pharmaceutical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pfizer
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mallinckrodt Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Endo International
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GlaxoSmithKline
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AstraZeneca
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Depomed
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novartis
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eli Lilly and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genentech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tonix Pharmaceuticals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NeuSpera Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oculis
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aspen Laser
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hyperice
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orofacial Therapeutics Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pain Care Labs
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

疼痛管理の市場規模、シェア、成長分析、タイプ別、適応症別、購入形態別、エンドユーザー別、地域別 - 産業予測、2024～2031年

Pain Management Market Size, Share, Growth Analysis, By Types (Non-Steroidal Anti-Inflammatory Drugs, Anticonvulsants), By Indication, By Mode of Purchase, By End-User, By Region - Industry Forecast 2024-2031

目次

イントロダクション

調査手法

エグゼクティブサマリー

市場力学と見通し

主な市場の考察

疼痛管理市場規模：タイプ別およびCAGR（2024～2031年）

疼痛管理市場規模：適応症別およびCAGR（2024～2031年）

疼痛管理市場規模：購入形態別およびCAGR（2024～2031年）

疼痛管理市場規模：エンドユーザー別およびCAGR（2024～2031年）

疼痛管理市場規模およびCAGR（2024～2031年）